Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/22/2010CA2541131C Derivatives of piperazine, process for their preparation and pharmaceutical compositions containing them
06/22/2010CA2540834C Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
06/22/2010CA2523379C Treatment of incontinence
06/22/2010CA2523253C Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
06/22/2010CA2514977C Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e)
06/22/2010CA2500575C New derivatives of 4-oxo-4,6,7,8-tetrhydro-pyrrolo[1,2-a]pyrazine-6-carbonxamides, their preparation process and the pharmaceutical compositions that contain them
06/22/2010CA2495875C Process for producing metered dose inhaler formulations
06/22/2010CA2492161C New derivatives of fluorinated benzothiadiazines, the process for preparing them and the pharmaceutical compounds that contain them
06/22/2010CA2485479C New 2-(.alpha.-hydroxypentyl) benzoates, their preparations and their uses
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2479991C Process for production of crystals, crystals obtained thereby and their use in pharmaceutical preparations
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2462149C Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/22/2010CA2461187C Lyophilized formulation
06/22/2010CA2448741C Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2443633C Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
06/22/2010CA2442296C Therapeutic agents for retinochoroidal disorders comprising steroids as active ingredients
06/22/2010CA2441398C Lipid lowering biphenylcarboxamides
06/22/2010CA2441071C Tsg101-gag interaction and use thereof
06/22/2010CA2439430C Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
06/22/2010CA2439062C Silicon implants comprising a radionuclide for use in brachytherapy
06/22/2010CA2434067C Materials and methods relating to protein aggregation in neurodegenerative disease
06/22/2010CA2430829C Rapidly disintegrating tablet comprising an acid-labile active ingredient
06/22/2010CA2428603C Prevention of development of dyskinesias with an alfa 2-adrenoceptor antagonist
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2412864C Methods of making, using and pharmaceutical formulations comprising 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one and 17 esters thereof
06/22/2010CA2412718C Viral polymerase inhibitors
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2410408C 2-aminoalkylthieno[2,3-d]pyrimidines
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2401655C Cardioprotective phosphonates and malonates
06/22/2010CA2401593C Infusion packet with useful and decorative elements, support member, delivery system and method
06/22/2010CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
06/22/2010CA2395493C Hyaluronic acid in the treatment of cancer
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2384059C Method of treating cancer using tetraethyl thiuram disulfide
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/22/2010CA2374346C Inhibitors of memapsin 2 and use thereof
06/22/2010CA2372457C Conditioning/styling terpolymers
06/22/2010CA2353905C Chemotherapeutic composition and method
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/22/2010CA2314818C Compositions of matter containing l-glutamine and pyridoxal-alpha-ketoglutarate
06/22/2010CA2302568C Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
06/22/2010CA2297198C Macrocyclic lactones, compositions, and methods of use
06/22/2010CA2290810C Linked maltodextrins and preparation process thereof
06/22/2010CA2277075C Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
06/22/2010CA2265480C Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
06/22/2010CA2256483C P13 lipid kinase
06/22/2010CA2242878C Induction of immune response against desired determinants
06/22/2010CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/22/2010CA2190943C Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
06/22/2010CA2134380C Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
06/17/2010WO2010068951A1 Combination therapy based on src and aurora kinase inhibition for the treatment of cancer
06/17/2010WO2010068947A2 Nuclear export inhibitors of topoisomerase ii alpha
06/17/2010WO2010068935A2 Small molecule immunomodulators for alzheimer's disease
06/17/2010WO2010068925A1 Combinations and modes of administration of therapeutic agents and combination therapy
06/17/2010WO2010068920A2 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010WO2010068918A2 Novel targets for treatment of hypercholesterolemia
06/17/2010WO2010068913A2 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
06/17/2010WO2010068899A1 Nanoparticles comprising combinations of antiretroviral agents and use thereof
06/17/2010WO2010068877A2 Compounds that bind oxysterol binding proteins, and methods of use thereof
06/17/2010WO2010068867A1 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
06/17/2010WO2010068866A2 Therapeutic particles suitable for parenteral administration and methods of making and using same
06/17/2010WO2010068863A2 Pyrimidine compounds and methods of making and using same
06/17/2010WO2010068815A2 Compositions and methods for treating cellular proliferative disorders
06/17/2010WO2010068810A2 Certain substituted amides, method of making, and method of use thereof
06/17/2010WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer
06/17/2010WO2010068794A2 Hif inhibitors and use thereof
06/17/2010WO2010068789A1 Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
06/17/2010WO2010068788A1 Heterocyclic amides as btk inhibitors
06/17/2010WO2010068775A2 Alkyne antagonists of lysophosphatidic acid receptors
06/17/2010WO2010068767A1 Small molecule activators of mitochondrial function
06/17/2010WO2010068760A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/17/2010WO2010068759A1 Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates
06/17/2010WO2010068750A2 Compositons and method for treatment of mood and cognitive impairments
06/17/2010WO2010068738A1 Mek mutations conferring resistance to mek inhibitors
06/17/2010WO2010068717A2 Pyrazolinone scavengers of free radicals
06/17/2010WO2010068714A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
06/17/2010WO2010068710A2 Kinase inhibitor compounds
06/17/2010WO2010068708A2 3'-azido purine nucleotide prodrugs for treatment of viral infections
06/17/2010WO2010068700A1 Antimicrobial molecules for treating multi-drug resistant and extensively drug resistant strains of mycobacterium
06/17/2010WO2010068696A1 Nutritional intervention for improving muscular function and strength
06/17/2010WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010WO2010068654A1 Sustained release systems of ascorbic acid phosphate
06/17/2010WO2010068605A1 Novel polymorphic forms of 4-[(4-methoxyphenyl)methyl]-5-(trifluoromethyl)-1h-pyrazole-3-yl]4-deoxy-4-fluoro-beta-d-glucopyranoside including hydrates thereof and the preparations thereof
06/17/2010WO2010068601A1 A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
06/17/2010WO2010068564A1 Method for treating alzheimer's disease and related conditions
06/17/2010WO2010068520A2 Substituted imidazoheterocycle derivatives
06/17/2010WO2010068500A2 PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
06/17/2010WO2010068483A2 Mlk inhibitors and methods of use
06/17/2010WO2010068480A1 Deuterated derivatives of dimeboline
06/17/2010WO2010068461A1 Co-administration of ranolazine and cardiac glycosides
06/17/2010WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010068452A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010068383A1 Novel rifamycin 3, 4- (3' -substituted aminomethyl) fused pyrrolo derivatives
06/17/2010WO2010068358A1 Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same
06/17/2010WO2010068311A1 5-lipoxygenase-activating protein inhibitor
1 ... 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 ... 7860